Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Desconocido
Fase 3
ClinicalTrials.gov
TREATMENT OF ALL IN FIRST BONE MARROW RELAPSE AFTER BFM PROTOCOLS
Intervencional
Inicio: 1 de ene de 1990
ID: NCT00002499
Terminado
Fase 2
ClinicalTrials.gov
A 5-year, Randomized, Double-blind, Placebo-controlled, Multi-center Study Assessing the Efficacy, Safety, and Tolerability of Intra-articular Regimens of LNA043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis
Intervencional
Inicio: 31 de may de 2021
ID: NCT04864392
Terminado
Fase 2
ClinicalTrials.gov
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Of The Safety And Efficacy Of PPM-204 In Subjects With Type 2 Diabetes
Intervencional
Inicio: 1 de ene de 2007
ID: NCT00425919
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Study of Neoadjuvant and Adjuvant Nivolumab Plus Bempegaldesleukin (NKTR-214), Versus Nivolumab Alone Versus Standard of Care in Participants With Muscle-Invasive Bladder Cancer (MIBC) Who Are Cisplatin Ineligible
Intervencional
Inicio: 5 de feb de 2020
ID: NCT04209114
Desconocido
ClinicalTrials.gov
Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group
Observacional
Inicio: 22 de nov de 2020
ID: NCT04640064
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Comparative Study To Assess Tolerability Of A Single Oral 60 Mg/Kg Dose Of Zmax (Pediatric Concentration) Vs. Zmax (Adult Concentration) In Pediatric Patients With Acute Otitis Media
Intervencional
Inicio: 1 de ago de 2006
ID: NCT00360100
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double Blind, Placebo Controlled, Phase II Trial Evaluating the Safety and Efficacy of Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer That Have Evidence of Disease Progression on or After Prior Endocrine Therapy
Intervencional
Inicio: 1 de abr de 2012
ID: NCT01528345
Terminado
Fase 2
ClinicalTrials.gov
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Intervencional
Inicio: 4 de ene de 2017
ID: NCT02975336
Completado
Fase 2
ClinicalTrials.gov
A Randomized Dose Ranging Study of Hexadecasaccharide Including Active Control, in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous Coronary Intervention (SHINE)
Intervencional
Inicio: 1 de dic de 2004
ID: NCT00123565
Completado
Fase 3
ClinicalTrials.gov
Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia-Folic Acid Clinical Trial (FACT)
Intervencional
Inicio: 1 de abr de 2011
ID: NCT01355159
Completado
Fase 2
ClinicalTrials.gov
A Phase 1 and 2 Clinical Trial of ALIMTA® (Pemetrexed) in Combination With Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer
Intervencional
Inicio: 1 de jul de 2005
ID: NCT00489359
Completado
Fase 2
ClinicalTrials.gov
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver
Intervencional
Inicio: 1 de mar de 2016
ID: NCT02724540
Completado
Fase 4
ClinicalTrials.gov
A Multicenter, Randomized, Double-Period, Double - Blind Study to Determine the Optimal Protocol for Treatment Initiation With Methotrexate and Adalimumab Combination Therapy in Patients With Early Rheumatoid Arthritis (OPTIMA)
Intervencional
Inicio: 1 de dic de 2006
ID: NCT00420927
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients With Heart Failure and Impaired Systolic Function
Intervencional
Inicio: 13 de ene de 2017
ID: NCT03016325
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Blind, Multicenter Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX™) vs. Exemestane (AROMASIN™) in Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer With Disease Progression After Prior Non-Steroidal Aromatase Inhibitor (AI) Therapy
Intervencional
Inicio: 1 de ago de 2003
ID: NCT00065325
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Blind, Placebo-Controlled, Study to Assess the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
Intervencional
Inicio: 6 de jul de 2017
ID: NCT03039686
Terminado
Fase 2
ClinicalTrials.gov
Phase 2 Non-randomized, Open-label, Multi-cohort, Multicenter Study Assessing the Clinical Benefit of SAR444245 (THOR-707) With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma
Intervencional
Inicio: 7 de dic de 2021
ID: NCT05179603
Completado
ClinicalTrials.gov
Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG)
Intervencional
Inicio: 11 de ene de 2022
ID: NCT05120388
Completado
Fase 3
ClinicalTrials.gov
A 12 Week Study to Evaluate the Effect of Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) 100/25 mcg Inhalation Powder Delivered Once Daily Via a Novel Dry Powder Inhaler (NDPI) on Arterial Stiffness Compared With Tiotropium Bromide 18 mcg Delivered Once Daily Via a HandiHaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Intervencional
Inicio: 30 de jun de 2011
ID: NCT01395888
Completado
Fase 3
ClinicalTrials.gov
Effects of LY333334 in the Treatment of Postmenopausal Women With Osteoporosis
Intervencional
Inicio: 1 de ago de 1996
ID: NCT00670501
Anterior
1
...
405
406
407
...
434
Siguiente
Filtros